A study of effect of anti-retroviral therapy regimen on metabolic syndrome in people living with HIV/AIDS: Post hoc analysis from a tertiary care hospital in western India
- 1 May 2021
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 15 (3) , 655-659
Abstract
No abstract availableKeywords
All Related Versions
This publication has 23 references indexed in Scilit:
- Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic reviewBMC Public Health, 2017
- Antitubercular therapy induced liver function tests abnormalities in human immunodeficiency virus infected individualsMedical Journal Armed Forces India, 2017
- Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260sOpen Forum Infectious Diseases, 2016
- Antiretroviral therapy: Shifting sandsMedical Journal Armed Forces India, 2016
- Metabolic syndrome in human immunodeficiency virus positive patientsIndian Journal of Endocrinology and Metabolism, 2013
- Metabolic Syndrome Before and After Initiation of Antiretroviral Therapy in Treatment-Naive HIV-Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2012
- Metabolic syndrome among HIV-infected Taiwanese patients in the era of highly active antiretroviral therapy: prevalence and associated factorsJournal of Antimicrobial Chemotherapy, 2012
- Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patientsInternational Journal of STD & AIDS, 2011
- Fifteen years of HIV Protease Inhibitors: raising the barrier to resistanceAntiviral Research, 2010
- Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and DiabetesDiabetes Care, 2007